The Next $900 Billion Stimulus

Fed Chairman Jerome Powell and the Federal Reserve are facing a very tricky moment. So far, the monetary response to the pandemic has been “fire-fighting.” That is, the Federal… Read more

Read more »

FDA Approves This Home Test

There is no doubt that this holiday season is one none of us have ever experienced. It will be strange not celebrating together with extended family and friends.  But… Read more

Read more »

Top 3 IPO Winners in December

You’re probably thinking that Airbnb (NASDAQ: ABNB) and DoorDash (NYSE: DASH) are the top IPOs. These stocks have certainly captured the headlines . . . Yet three less well-known… Read more

Read more »

Dr. Fauci FINALLY Shares Good News

Yesterday was the day that America finally got a “shot of hope.” The first shots of Covid vaccine were given to front-line healthcare workers on Monday. Ironically, it was… Read more

Read more »

The Biggest IPOs to Buy in 2021

This is the biggest year for IPOs since 1999 . . . With blockbuster deals including Airbnb +86% . . . Big Commerce +201% . . .  and CureVac… Read more

Read more »

U.S. Buys 200 Million Vaccines from This Company

A growing body of evidence suggests why young children account for only a small percentage of Covid infections. Their immune systems seem better equipped to fend off SARS-CoV-2 than… Read more

Read more »

Operation Warp Speed’s Biggest Success

The FDA has signaled it plans to approve the Pfizer BioNTech vaccine very soon. This follows the vote at the FDA advisory group of outside scientific advisors on Thursday…. Read more

Read more »

JP Morgan Issues Tesla Warning

Analysts at JP Morgan just issued an urgent warning . . . Tesla Motors stock is very, very overvalued. The firm rates Tesla Motors stock an “Underperform” – which… Read more

Read more »

FDA Approves Pfizer Vaccine Today

FDA is widely expected to approve emergency use authorization (EUA) today for the vaccine from Pfizer and BioNTech. In trials, the Pfizer vaccine had an efficacy rate of 95%… Read more

Read more »
To top